Elizabeth Holmes delays prison report date with another appeal
Disgraced Theranos founder Elizabeth Holmes will no longer report to prison to begin serving her 11.25-year sentence after issuing a last-minute appeal.
What Is Ozempic and why is it such a big deal right now?
Demand for medications including Ozempic, for weight loss use, led to shortages that sometimes deprived people with diabetes of their prescription refills.
Apple developing AI-powered health coaching service, emotional tracking tools: report
Apple is said to be developing a new A.I.-powered health coaching service to motivate users to exercise as well as new tools to track users' emotional health.
Narcan maker aims to make overdose reversal drug more affordable, company says
Emergent BioSolutions is aiming to make Narcan more affordable after the Food and Drug Administration approved sales of the live-saving without a prescription.
Former Theranos exec Sunny Balwani begins 13-year prison sentence in California
Ex-Theranos president Ramesh "Sunny" Balwani, the former top deputy and boyfriend of founder Elizabeth Holmes, has reported to a California prison to begin serving his fraud sentence.
J&J lifts profit forecast as cancer drugs, Stelara buoy pharma unit
A recovery in medical procedures after being weighed down by hospital staffing shortages helped the medical device unit post sales of $7.48 billion, topping estimates of $7.31 billion.
Merck to acquire Prometheus Biosciences for $10.8B
San Diego, California-based Prometheus Biosciences has a drug in development that treats immune diseases including ulcerative colitis and Crohn’s disease.
Mexico frozen strawberry supplier linked to recent Hepatitis A outbreak, identical to 2022 cases: FDA
A Mexico-based organic strawberry supplier in Baja California has been linked to a Hepatitis A virus outbreak with a strain identical to an outbreak in 2022.
Former Outcome Health executives found guilty of fraud
A federal jury convicted three former executives of the once-high-flying startup Outcome Health on charges they ran a billion-dollar scheme that defrauded customers.
Medical-device makers gain amid return to normalcy
Many of the top large-cap device makers reported relatively rosy fourth-quarter earnings while issuing 2023 guidance that was above analyst expectations.
Medicare beneficiaries would need more than $300,000 for healthcare costs in retirement: EBRI
Medicare beneficiaries in retirement would need to have saved anywhere from $96,000 to $383,000 to cover most of their healthcare needs, according to EBRI. The organization found that in general, Medicare Advantage enrollees have lower savings targets. But these private industry plans have their pros and cons.
Elizabeth Holmes loses bid to remain out of prison during appeal
Disgraced Theranos founder Elizabeth Holmes will report to prison on April 27 after a judge denied her request to remain on house arrest while she appeals her fraud convictions.
Drug companies blast Texas judge for abortion drug decision, call for reversal
Hundreds of pharmaceutical firms including Pfizer wrote an open letter condemning a federal judge in Texas who halted the approval of abortion drug mifepristone.
Abortion pill manufacturer Danco Laboratories slams Texas judge's ruling halting FDA approval of mifepristone
Drug manufacturer Danco Laboratories slammed a decision by a Texas judge to halt FDA approval of their abortion pill Mifeprex (mifepristone), vowing to appeal the decision.
Most US adults oppose Social Security, Medicare cuts, poll shows
A recent poll found that the majority of American adults are opposed to cutting Medicare or Social Security benefits. More than half are against raising monthly premiums for Medicare.
Johnson & Johnson to pay $8.9B to resolve claims baby powder, talc products caused cancer
Johnson & Johnson said Tuesday that it would pay $8.9 billion to resolve all current and future allegations that its baby powder containing talc caused cancer.
FTC orders Illumina to unwind $7B deal for cancer test developer Grail
The Federal Trade Commission has rejected Illumina's $7.1 billion acquisition of cancer detection test maker Grail, saying the deal would stifle competition.
Opioid overdose drug Narcan approved for over-the-counter use by FDA
The U.S. Food and Drug Administration announced Wednesday it approved selling the life-saving naloxone-based nasal spray Narcan without a prescription.
Novartis shares jump on breast cancer drug trials success
Novartis said the drug showed positive topline results from an interim analysis of NATALEE in a broad population of patients with early breast cancer.
Rand Paul slams Moderna CEO on failing to concede to studies on rare heart inflammation due to vaccine
Sen. Rand Paul slammed Moderna CEO Stephane Bancel during a Wednesday Senate hearing over the CEO's rebuking of studies showing negative side effects after receiving the Moderna vaccine.